Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenabasum in Systemic Lupus Erythematosus
NCT03093402Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2017
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenabasum in systemic lupus erythematosus (SLE), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2017; status: completed.
02
Drugs
lenabasum
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03093402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03093402.